Modulation of oligonucleotide CpGmediated immune stimulation by positional modification of nucleosides

Details for Australian Patent Application No. 2001257366 (hide)

Owner Idera Pharmaceuticals, Inc.

Inventors Agrawal, Sudhir

Agent Freehills

Pub. Number AU-B-2001257366

PCT Pub. Number WO01/83503

Priority 60/201,578 01.05.00 US

Filing date 30 April 2001

Wipo publication date 12 November 2001

Acceptance publication date 16 March 2006

International Classifications

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

16 March 2006 Application Accepted

  Published as AU-B-2001257366

23 March 2006 Assignment before Grant

  Hybridon, Inc. The application has been assigned to Idera Pharmaceuticals, Inc.

13 July 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001257367

2001257365